OpenVSafe by OpenVAERS
Search V-safe

4KQ-22162-11311

3 vaccinations 1 coded response 15 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
941 / CA
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-08
    Registered in v-safe
  3. 2021-04-08
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-08
    Health check-in — day 0, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  5. 2021-04-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Abdominal pain
    Adult check-in
  7. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-04-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-05-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-07-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-12-05
    Dose 3 — Pfizer-BioNTech
  17. 2022-04-08
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-06-05
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-12-05
    Survey response — 12 months, dose 3
    MedDRA: Oropharyngeal pain, Respiratory tract congestion, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Extreme congestion, sore throat, sneezing
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-12-05
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  21. 2022-12-06

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Pfizer-BioNTech
22021-04-08Pfizer-BioNTech
32021-12-05Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-12-05 Unsuccessful

Free text

Release 12 — 12 months, dose 3

2022-12-05

Symptoms: Extreme congestion, sore throat, sneezing

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDOropharyngeal pain · · ✓
SDRespiratory tract congestion · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release